Neuregulin 3 Knockout Mice Exhibit Behaviors Consistent with Psychotic Disorders
Author(s) -
Lindsay N. Hayes,
A. V. Shevëlkin,
Mariela Zeledón,
Gary Steel,
PeiLung Chen,
Cassandra Obie,
Ann E. Pulver,
Dimitrios Avramopoulos,
David Valle,
Akira Sawa,
Mikhail V. Pletnikov
Publication year - 2016
Publication title -
complex psychiatry
Language(s) - English
Resource type - Journals
eISSN - 2673-3005
pISSN - 2673-298X
DOI - 10.1159/000445836
Subject(s) - neuregulin 1 , knockout mouse , neuregulin , neuroscience , psychology , schizophrenia (object oriented programming) , chemistry , psychiatry , receptor , biochemistry
Neuregulin 3 (NRG3) is a paralog of NRG1. Genetic studies in schizophrenia demonstrate that risk variants in NRG3 are associated with cognitive and psychotic symptom severity, and several intronic single nucleotide polymorphisms in NRG3 are associated with delusions in patients with schizophrenia. In order to gain insights into the biological function of the gene, we generated a novel Nrg3 knockout (KO) mouse model and tested for neurobehavioral phenotypes relevant to psychotic disorders. KO mice displayed novelty-induced hyperactivity, impaired prepulse inhibition of the acoustic startle response, and deficient fear conditioning. No gross cytoarchitectonic or layer abnormalities were noted in the brain of KO mice. Our findings suggest that deletion of the Nrg3 gene leads to alterations consistent with aspects of schizophrenia. We propose that KO mice will provide a valuable animal model to determine the role of the NRG3 in the molecular pathogenesis of schizophrenia and other psychotic disorders.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom